Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
76
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
96
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
NeoGenomics
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Advanced Oncology Diagnostics And NGS Capabilities Will Create Future Opportunities
Key Takeaways Launch of new liquid biopsy products and expanding test offerings position the company to capture market share and benefit from growth in oncology diagnostics demand. Investments in digital capabilities and strategic partnerships drive operational efficiency, support higher margins, and set up sustained earnings momentum.
View narrative
US$8.61
FV
32.6% undervalued
intrinsic discount
9.02%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
3 days ago
author updated this narrative
Genius Group
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Easing Legal Hurdles Will Unleash AI Edtech And Bitcoin Expansion
Key Takeaways Lifting of legal restrictions and legal resolutions may boost platform growth, product launches, and financial stability while lowering extraordinary costs and supporting future earnings potential. Expansion of AI-driven, personalized learning and unified edtech offerings under the Genius brand is expected to increase user engagement, recurring revenue, and global market reach.
View narrative
US$4.30
FV
77.3% undervalued
intrinsic discount
54.87%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
3 days ago
author updated this narrative
TPXimpact Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
UK Government Spending And AI Integration Will Redefine Digital Services
Key Takeaways Strategic focus on public sector digital transformation and strong government relationships position the company for revenue growth and improved contract quality. Integration of AI, operational streamlining, and regulatory tailwinds enhance efficiency, margin expansion, and stability of recurring revenues.
View narrative
UK£0.67
FV
71.4% undervalued
intrinsic discount
5.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
3 days ago
author updated this narrative
ANGLE
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Pharma Partnerships And Liquid Biopsy Will Expand Future Markets
Key Takeaways ANGLE's unique technologies and partnerships in precision oncology position it for strong, margin-expanding revenue growth as liquid biopsy adoption accelerates. Ongoing innovation, clinical validation, and disciplined cost management enhance ANGLE's competitive strength, diversify revenues, and improve long-term profitability.
View narrative
UK£0.28
FV
81.3% undervalued
intrinsic discount
138.15%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
Fortress Biotech
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
FDA Approval Will Open $1 Billion Dermatology Market
Key Takeaways Emrosi's successful launch and growing market adoption are expected to drive significant revenue growth, improved operating leverage, and expanding net margins. Strategic international out-licensing could deliver non-dilutive income, strengthen cash flow, and support global expansion without requiring additional capital.
View narrative
US$10.00
FV
81.8% undervalued
intrinsic discount
49.50%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
3 days ago
author updated this narrative
HBR Realty Empreendimentos Imobiliários
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Mogi Das Cruzes And ComVem Will Increase Rentals Despite Headwinds
Key Takeaways Strategic expansion and increased occupancy in key properties are expected to drive revenue growth and improve rental income. Asset recycling and strategic disposals are aimed at debt reduction and enhanced capital efficiency, potentially boosting earnings and net margins.
View narrative
R$11.88
FV
69.6% undervalued
intrinsic discount
30.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
Inuvo
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Privacy First AI Targeting Will Open Digital Advertising Markets
Key Takeaways Accelerating adoption of Inuvo's privacy-focused, AI-driven platform positions the company for scalable, high-margin, and sustainable revenue growth in a shifting digital advertising landscape. Investments in compliance, direct client relationships, and omnichannel solutions enhance operational efficiency, client retention, and profitability amid expanding industry demand.
View narrative
US$13.50
FV
71.4% undervalued
intrinsic discount
15.14%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
3 days ago
author updated this narrative
Vantiva
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Legacy Video Decline And Broadband Upside Will Shape Future Trends
Key Takeaways Ongoing decline in legacy video products and customer concentration pose risks to revenue stability and future earnings resilience. Increased competition, regulatory pressures, and evolving technologies threaten margins, profitability, and the company's ability to differentiate its offerings.
View narrative
€0.10
FV
39.0% overvalued
intrinsic discount
-1.44%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Creo Medical Group
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Minimally Invasive Interventions Will Capture New Global Markets
Key Takeaways Expanding global demand and healthcare trends strongly favor Creo's advanced energy portfolio, driving sustained growth in market share, revenue, and profit margins. Strategic alliances, new product launches, and cost-saving operational changes are set to accelerate international expansion, boost utilization, and improve overall profitability.
View narrative
UK£0.71
FV
81.4% undervalued
intrinsic discount
63.76%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
3 days ago
author updated this narrative
Value any company in seconds
Popular companies